• 文献标题:   Graphene quantum dots based magnetic nanoparticles as a promising delivery system for controlled doxorubicin release
  • 文献类型:   Article
  • 作  者:   JAVADIAN S, NAJAFI K, SADRPOOR SM, EKTEFA F, DALIR N, NIKKHAH M
  • 作者关键词:   controlled release, drug delivery, graphene quantum dot, fickian transport, quantum computation, adsorption energy
  • 出版物名称:   JOURNAL OF MOLECULAR LIQUIDS
  • ISSN:   0167-7322 EI 1873-3166
  • 通讯作者地址:  
  • 被引频次:   13
  • DOI:   10.1016/j.molliq.2021.115746 EA MAR 2021
  • 出版年:   2021

▎ 摘  要

In this study, a nanocarrier was prepared for targeted delivery of doxorubicin (DOX), as a drug model, to cancer cells. To this end, nontoxic Fe3O4 nanoparticles (NPs) were first synthesized by the co-precipitation method. The NPs then underwent surface functionalization by hydrophilic and biocompatible polyethylene glycol (PEG) to improve their stability. The Fe3O4@PEG was eventually decorated by graphene quantum dots (GQDs) for imparting specific optical properties and increase its drug loading capacity. The obtained nanocarriers (Fe3O4@PEG@GQD) exhibited low toxicity, hydrodynamic diameter of 129 nm, and a drug loading content of 27%, along with superior superparamagnetic properties. Also, the morphology of nanocarrier was surveyed by transmission electron microscopy (TEM). The drug release studies indicated a pH-dependent profile where higher release rates were observed at acidic pH (5.0) as compared with the physiological pH (7.4). The anticancer activity of Fe3O4@PEG@GQD-DOX was comparable to free drugs in the case of human breast cancer cells. The introduced nano-drug delivery system can be considered as a promising candidate for the controlled release of DOX. Finally, quantum mechanical computations were employed in a better understanding of drug release mechanism. The results showed a decline in the adsorption energy of the drug on GQDs from - 107.1 kJ mol(-1) at pH 7 to -66.2 kJ mol(-1) at pH 5. Moreover, the HOMO-LUMO calculation and the electrostatic surface potential method were applied to further explore the drug-GQDs interactions. (C) 2021 Published by Elsevier B.V.